跳至主要内容
临床试验/NCT04949230
NCT04949230已完成不适用

A Retrospective Study to Analyze Efficacy of COVID-19 Treatments

ProgenaBiome1 个研究点 分布在 1 个国家目标入组 300 人开始时间: 2021年2月19日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
300
试验地点
1
主要终点
Survey Response

研究概览

简要总结

Surveys administered to subjects who have recovered from COVID-19 to assess how effective their treatment was.

详细描述

Subjects who have recovered from COVID-19 will answer questions regarding the severity of their illness, symptoms experienced, what treatment they received, and how long they were ill.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Retrospective

入排标准

年龄范围
18 Months 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Signed informed consent, demonstrating that the patient understands the procedures required for the study and the purpose of the study
  • Male or female of 18 years of age or older
  • Diagnosis of COVID-19 infection by RT- PCR
  • Recovery from COVID-19

排除标准

  • 未提供

结局指标

主要结局

Survey Response

时间窗: One hour

Answers given by subjects on their recovery from COVID-19

次要结局

未报告次要终点

研究者

发起方
ProgenaBiome
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验